Richard D Wilson1, Stephen J Page2, Michael Delahanty3, Jayme S Knutson4, Douglas D Gunzler5, Lynne R Sheffler4, John Chae4. 1. MetroHealth Rehabilitation Institute, MetroHealth Medical Center, Cleveland, OH, USA Case Western Reserve University, Cleveland, OH, USA Cleveland FES Center, Cleveland, OH, USA rwilson@metrohealth.org. 2. The Ohio State University, Columbus, OH, USA. 3. Akron General Medical Center, Akron, OH, USA Northeast Ohio Medical University, Rootstown, OH, USA. 4. MetroHealth Rehabilitation Institute, MetroHealth Medical Center, Cleveland, OH, USA Case Western Reserve University, Cleveland, OH, USA Cleveland FES Center, Cleveland, OH, USA. 5. Case Western Reserve University, Cleveland, OH, USA.
Abstract
BACKGROUND AND PURPOSE: This study compared the effect of cyclic neuromuscular electrical stimulation (NMES), electromyographically (EMG)-triggered NMES, and sensory stimulation on motor impairment and activity limitations in patients with upper-limb hemiplegia. METHODS: This was a multicenter, single-blind, multiarm parallel-group study of nonhospitalized hemiplegic stroke survivors within 6 months of stroke. A total of 122 individuals were randomized to receive either cyclic NMES, EMG-triggered NMES, or sensory stimulation twice every weekday in 40-minute sessions, over an 8 week-period. Patients were followed for 6 months after treatment concluded. RESULTS: There were significant increases in the Fugl-Meyer Assessment [F(1, 111) = 92.6, P < .001], FMA Wrist and Hand [F(1, 111) = 66.7, P < .001], and modified Arm Motor Ability Test [mAMAT; time effect: F(1, 111) = 91.0, P < .001] for all 3 groups. There was no significant difference in the improvement among groups in the FMA [F(2, 384) = 0.2, P = .83], FMA Wrist and Hand [F(2, 384) = 0.4, P = .70], or the mAMAT [F(2, 379) = 1.2, P = .31]. CONCLUSIONS: All groups exhibited significant improvement of impairment and functional limitation with electrical stimulation therapy applied within 6 months of stroke. Improvements were likely a result of spontaneous recovery. There was no difference based on the type of electrical stimulation that was administered.
RCT Entities:
BACKGROUND AND PURPOSE: This study compared the effect of cyclic neuromuscular electrical stimulation (NMES), electromyographically (EMG)-triggered NMES, and sensory stimulation on motor impairment and activity limitations in patients with upper-limb hemiplegia. METHODS: This was a multicenter, single-blind, multiarm parallel-group study of nonhospitalized hemiplegic stroke survivors within 6 months of stroke. A total of 122 individuals were randomized to receive either cyclic NMES, EMG-triggered NMES, or sensory stimulation twice every weekday in 40-minute sessions, over an 8 week-period. Patients were followed for 6 months after treatment concluded. RESULTS: There were significant increases in the Fugl-Meyer Assessment [F(1, 111) = 92.6, P < .001], FMA Wrist and Hand [F(1, 111) = 66.7, P < .001], and modified Arm Motor Ability Test [mAMAT; time effect: F(1, 111) = 91.0, P < .001] for all 3 groups. There was no significant difference in the improvement among groups in the FMA [F(2, 384) = 0.2, P = .83], FMA Wrist and Hand [F(2, 384) = 0.4, P = .70], or the mAMAT [F(2, 379) = 1.2, P = .31]. CONCLUSIONS: All groups exhibited significant improvement of impairment and functional limitation with electrical stimulation therapy applied within 6 months of stroke. Improvements were likely a result of spontaneous recovery. There was no difference based on the type of electrical stimulation that was administered.
Authors: Winston D Byblow; Cathy M Stinear; P Alan Barber; Matthew A Petoe; Suzanne J Ackerley Journal: Ann Neurol Date: 2015-11-17 Impact factor: 10.422
Authors: Mohammad Ghassemi; Kristen Triandafilou; Alex Barry; Mary Ellen Stoykov; Elliot Roth; Ferdinando A Mussa-Ivaldi; Derek G Kamper; Rajiv Ranganathan Journal: IEEE Trans Neural Syst Rehabil Eng Date: 2019-01-21 Impact factor: 3.802
Authors: Jan C Kattenstroth; Tobias Kalisch; Matthias Sczesny-Kaiser; Wolfgang Greulich; Martin Tegenthoff; Hubert R Dinse Journal: BMC Neurol Date: 2018-01-09 Impact factor: 2.474
Authors: Martina Coscia; Maximilian J Wessel; Ujwal Chaudary; José Del R Millán; Silvestro Micera; Adrian Guggisberg; Philippe Vuadens; John Donoghue; Niels Birbaumer; Friedhelm C Hummel Journal: Brain Date: 2019-08-01 Impact factor: 13.501